Table 2.
Cellular processes affected | Protein | Disease | Study models | Methods | Effects of PLSCR1 interaction | References |
---|---|---|---|---|---|---|
Nuclear import | Importin-α | N.A | Murine SVT2 fibroblasts |
- Fluorescence Anisotropy Assay - Crystallographic Analysis |
Favors PLSCR1 entrance into the nucleus | [16] |
- Cell migration - Invasion - Stemness |
STAT3 | BLBC |
- MDA -MB231 - SUM159 - MCF7 - HCC1937 - T47D - MDA -MB468 |
- MS - CO-IP |
Activates STAT1 transcription thus inducing cancer stem cell properties | [81] |
Cell differentiation | IP3R1 promoter | AML | Primary leukemia cells | EMSA | Induces cell cycle arrest and cell differentiation promoted by Wogonoside | [43, 77] |
Cell signaling |
TOPO IIα TOPO IIβ |
N.A | HeLa |
- Yeast two hybrid screening - GST-pull-down assay - CO-IP |
Increases DNA decatenating ability of Topo IIα | [15] |
Cell proliferation |
ANG MK |
N.A Hepatic carcinoma |
HeLa HepG2 |
- Yeast two hybrid screening - GST-pull-down assay - CO-IP - FRET |
Positively regulates rRNA transcription | [83] |
- GST-pull-down assay - CO-IP |
Promotes cell proliferation and migration | [80] |
N.A. Not applicable, PLSCR1 Phospholipid scramblase 1, BLBC Basal-like breast cancer, STAT3 Signal Transducer And Activator Of Transcription 3, STAT1 Signal Transducer And Activator Of Transcription 1, MS Mass spectrometry, CO-IP co-immunoprecipitation, IP3R1 1,4,5-trisphosphate receptor 1, AML acute myeloid leukemia, EMSA Electrophoretic mobility shift assay, TOPO II DNA topoisomerase II, ANG Angiogenin, FRET fluorescent resonance energy transfer, MK Midkine